-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - Table D. … Goldstraw P, Ball D, Jett JR, et al. Non-small-cell lung cancer. … Owens DK, Lohr KN, Atkins D, et al. … Mallick I, Sharma SC, Behera D, et al. … Image-guided thermal ablation of lung malignancies.
Radiology. 2011 Sep;260(3):633-55.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol.pdf
January 30, 2023 - hormone-related cancers, a high risk of cancer, or conditions such as primary
ovarian insufficiency … , breast cancer recurrence or
progression, breast tenderness, cardiovascular risk,
endometrial cancer … D. … GRADE guidelines: 11. … rabbits or rat or rats).ti,ab. 3287242
18 Penile Erection/ or Erectile Dysfunction/ or Prostatic Neoplasms
-
effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research-protocol
July 21, 2014 - These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … , grade, size, or molecular/genetic markers? … , grade, size, or molecular/genetic markers? … D. … References
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013.
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-staging/research-protocol
May 21, 2013 - Although we have grouped all colon and rectal cancers together as “colorectal cancer” as an inclusion … Yabroff KR, Lund J, Kepka D, et al. … D
IVB
Any T
Any N
M1b
D
D
Appendix B. … exp Colorectal Neoplasms/ or exp colon cancer/ or exp colon tumor/ or exp rectum cancer/ or exp rectum … $)).ti,ab.
2
Staging
neoplasm staging/ or cancer staging/ or (stag$ or restag$ or re-stag$).ti,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
February 01, 2008 - e.g., Gleason score, tumor volume,
screen vs. clinically detected tumors) affect the
outcomes of interventions … How do tumor characteristics, e.g., Gleason score,
tumor volume, screen vs. clinically detected
tumors … Men
with low-grade prostate cancers had a minimal risk of
dying from prostate cancer (7 percent with … Men with high-
grade prostate cancers had a high probability of dying
from their disease within 10 years … d. Trial 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - step in
the development of all tumors. … The final choice of which outcomes to grade will be based on rankings of the
potential impact of OC … of detected cancers:
results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer … Beral V, Bull D, Green J, et al. … Moher D, Liberati A, Tetzlaff J, et al.
-
effectivehealthcare.ahrq.gov/products/liver-cancer-therapy/research-protocol
March 20, 2012 - Disease is staged from 0 to D. … D. … PMID: 10806978
Moher D, Pham B, Lawson ML, et al. … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
January 01, 2020 - cancer recurrence. … We classified evidence pertaining to Key Questions
1 through 6 into four categories: (1) “high” grade … research is very unlikely to
change our confidence in the estimate of the effect);
(2) “moderate” grade … The team members discussed the process they used to
grade the evidence throughout the report writing … When a team member felt the evidence grade was
questionable, this comparison-outcome evidence grade
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
October 01, 2014 - Executive Summary
Background and Objectives
Hepatocellular carcinoma (HCC) is
the most common primary malignant … neoplasm of the liver, usually developing
in individuals with chronic liver disease
or cirrhosis. … Table D. … Kansagara D, Papak J, Pasha A, et al. … Atkins D, Chang SM, Gartlehner G, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/genitourinary-symptoms-protocol_0.pdf
July 10, 2023 - cancers, a high risk of cancer, or conditions such as primary
ovarian insufficiency, women experiencing … , breast cancer recurrence or
progression, breast tenderness, cardiovascular risk,
endometrial cancer … D. … GRADE guidelines: 11. … rabbits or rat or rats).ti,ab. 3287242
18 Penile Erection/ or Erectile Dysfunction/ or Prostatic Neoplasms
-
effectivehealthcare.ahrq.gov/products/breast-abnormalities-tests-update/research-protocol
June 28, 2010 - Breast cancer is the second most common malignancy of women. 2 The American Cancer Society estimates … delay that may allow the tumor to spread and become life-threatening. … D. … Moher D, Pham B, Klassen KF, et al. … Owens D, Lohr K, Atkins D, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - d. … d. … Diagnostic management of pancreatic cancer. Cancers.
2011 Mar;3(1):494-509.
5. … exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or
neoplasms/)) or pancreas tumor/ or Pancreatic … r$ or sarcoma$ or neoplasm$ or
carcinoma$ or adenocarcinoma$)).mp.
4 neuroendocrine tumors/ and
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-treatment-localized-muscle-invasive-bladder-cancer
January 24, 2013 - How do tumor characteristics (i.e. stage, grade, multiplicity, size, molecular and genetic alterations … among African Americans despite adjustment of age, stage and grade. … Seattle Cancer Care Alliance 2012;
Yee D, Ishill M, Lowrance W et al: Ethnic differences in bladder … (Messing 2002)
Messing EM: Urothelial tumors of the urinary tract. … for 90% of all malignant tumors.
-
effectivehealthcare.ahrq.gov/products/radiation-brain-metastases/protocol
January 28, 2020 - Sperduto PW, Kased N, Roberge D, et al. … Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer … Tsao MN, Rades D, Wirth A, et al. … Ammirati M, Nahed BV, Andrews D, et al. … OR cancer* OR neoplasm* OR carcinoma* OR metastasectomy)))
AND
(MH "Radiosurgery") OR TI(radiation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes. … Samson D, Schoelles KM. … Samson D, Schoelles KM. … Samson D, Schoelles KM. … Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes. … Samson D, Schoelles KM. … Samson D, Schoelles KM. … Samson D, Schoelles KM. … Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbi-protocol.pdf
August 09, 2021 - of PBI, such as larger tumor size (2-3 cm), high tumor grade, close margins, human
epidermal growth … grade
• Tumor size (i.e., <1 cm, 1-2 cm, 2-3 cm, >3 cm)
• Focality (unifocal vs multifocal)
• Margin … Global cancer statistics 2020: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers … Smith TE, Lee D, Turner BC, et al. … Wells GA, Shea B, O'Connell D, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
October 10, 2019 - Sperduto PW, Kased N, Roberge D, et al. … Effect of tumor subtype on survival and the
graded prognostic assessment for patients with breast cancer … Tsao MN, Rades D, Wirth A, et al. … Ammirati M, Nahed BV, Andrews D, et al. … OR cancer* OR neoplasm* OR
carcinoma* OR metastasectomy)))
AND
(MH "Radiosurgery") OR TI(radiation
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
April 01, 2013 - "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND
("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND
("progression-free survival … "[Mesh] OR (breast AND (cancer OR cancers OR neoplasms OR carcinoma*)) AND
("progression-free survival … "[Mesh] OR ((ovary OR ovarian) AND (cancer OR cancers OR neoplasms OR
carcinoma*))) AND ("progression-free … ") AND (cancer OR cancers OR carcinoma* OR neoplasms))) AND
("progression-free survival" OR "time to
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
July 01, 2010 - Breast cancer is the second most common malignancy of women.2 The American
Cancer Society estimates … , a delay that may allow the tumor to spread and become life-
threatening. … D. … Moher D, Pham B, Klassen KF, et al. … Owens D, Lohr K, Atkins D, et al.